Age-related Macular Degeneration
📧 Sign up to get email alerts when something new happens for Age-related Macular Degeneration.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Advancing Understanding of Transportation Options [NA]
Completed clinical trial update from University of Colorado, Denver examining transportation options across multiple conditions; results pos…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Optical Coherence Tomography and Microperimetry Biomarker Evaluation in Patients With Geographic Atrophy Study
A completed clinical trial evaluating optical coherence tomography and microperimetry biomarkers in geographic atrophy due to age-related ma…
-
CLINICAL_TRIALS trial_result · 2025-02-18Clinical Trial Update: A Study to Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy [Phase 1]
Phase 1 study evaluating tolerability of escalating doses of BI 771716 in people with geographic atrophy, an advanced form of age-related ma…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Study of JMKX003948 Ophthalmic Suspension in Healthy Participants [Phase 1]
Phase 1 clinical trial update for JMKX003948 Ophthalmic Suspension in healthy participants; study status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: OcuDyne System in the Treatment of AMD [NA]
The clinical trial update reports that the OcuDyne System trial for age-related macular degeneration has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-02-12FDA Approved: IZERVAY — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for IZERVAY (avacincaptad pegol) submitted by Astellas Pharma US, Inc.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration [Phase 1]
A Phase 1 study is evaluating the safety of CG-P5 peptide eye drops in patients with age-related macular degeneration and is currently recru…
-
EMA withdrawal · 2025-02-04EMA Application withdrawn: Izelvay (avacincaptad pegol) — Astellas Pharma Europe B.V.
EMA has withdrawn the marketing authorization application for Izelvay (avacincaptad pegol) submitted by Astellas Pharma Europe B.V. for geog…
-
CLINICAL_TRIALS withdrawal · 2025-02-03Clinical Trial Update: Efficacy and Safety Study of CNTO 2476 in Participants With Visual Acuity Impairment Associated With Geographic Atrophy (GA) Secondary to Age Related Macular Degeneration (AMD) [Phase 2]
Phase 2 trial evaluating CNTO 2476 for visual acuity impairment due to geographic atrophy from age-related macular degeneration has been wit…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Preparation of Patient Autologous Induced Pluripotent Stem Cell-derived Retinal Cells for AMD
A clinical trial update indicates a study planning to use patient-specific autologous iPSC-derived retinal cells for age-related macular deg…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Development of Novel Clinical Endpoints in Intermediate AMD
This clinical trial update discusses development and validation of novel clinical endpoints for intermediate age-related macular degeneratio…
-
CLINICAL_TRIALS research · 2025-01-16Clinical Trial Update: Multicenter Real-life Observational Study Switched Aflibercept or Ranibizumab to Faricimab in Patients With AMD.
A multicenter real-world observational study is evaluating switching patients with age-related macular degeneration from aflibercept or rani…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
This clinical trial update describes an observational study to assess endpoint feasibility and measurement properties in patients with retin…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Visual Activity Evoked by Infrared in Humans After Dark Adaptation [NA]
A University of New Mexico–sponsored trial evaluating infrared visual activity after dark adaptation in people with age-related macular dege…
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: The Focal Electro-Oculogram in Macular Disease
Completed clinical trial evaluating the focal electro-oculogram as a diagnostic tool in age-related macular degeneration. The study was spon…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Targeted Fluorescence Imaging in AMD [Phase 1]
Phase 1 clinical trial update on a targeted fluorescence imaging approach for age-related macular degeneration; the study has completed.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD [NA]
A multicenter clinical study investigating SING-IMT for late-stage age-related macular degeneration, including geographic atrophy, is curren…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD [NA]
Update on a clinical trial evaluating the PRIMA System to restore central vision in geographic atrophy due to age-related macular degenerati…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Ocular Safety and Usability Study for FYB201 PFS [Phase 4]
Phase 4 ocular safety and usability study of FYB201 PFS has been completed, evaluating safety and usability in age-related macular degenerat…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Ocular Safety and Usability Study for FYB203 PFS [Phase 4]
Phase 4 ocular safety and usability study of FYB203 PFS has completed, evaluating safety outcomes and usability in age-related macular degen…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: BCI and Evaluation of Visual and Task Performance in Subjects With Eye Diseases [NA]
A completed clinical trial update describes a brain-computer interface (BCI) study assessing visual and task performance in subjects with ey…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Aflibercept in Recurrent or Persistent CNV
This clinical trial update indicates recruitment for a study of aflibercept in recurrent or persistent choroidal neovascularization. The con…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration [Phase 1]
Phase 1 study evaluating implantation of retinal pigment epithelium for acute wet age-related macular degeneration; the trial status is comp…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Retinal Pigment Epithelium Safety Study for Patients in B4711001
This clinical trial update from Moorfields Eye Hospital NHS Foundation Trust notes a study (NCT03102138) evaluating retinal pigment epitheli…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Early Feasibility Study Using IOPCL MAG to Improve Near Vision in ARMD Subjects
This clinical trial update reports results from an early feasibility study evaluating the IOPCL MAG to improve near vision in subjects with …